TB is a top priority for R&D

The Hague – KNCV Tuberculosis Foundation today shares in the outrage expressed by our partners in the TB community regarding the exclusion of  tuberculosis from the recently published WHO list of antibiotic-resistant “priority pathogens”. On February 28th, the WHO responded by stating that “addressing drug-resistant TB research is a top priority for WHO and for the world” given the “global consensus that new TB treatments are already a top priority for R&D”. KNCV welcomes this needed clarification and looks forward to accelerated action following the Global Ministerial Conference on TB in Moscow in November of this year. It is KNCV’s conviction that this event, and other platforms for collaboration and effective partnerships, will have a significant impact in ending the global TB epidemic. Therefore, let us take immediate action to demand further investment in development of novel drugs to treat drug resistant TB and halting the needless suffering incurred by communities, families and patients.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.